Global Ureteroscope Market Size By Type (Flexible Ureteroscope, Semi- Rigid Ureteroscope), By Application (Hospitals, Urology Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Ureteroscope Market was valued at USD 1.3 billion in 2023 and is projected to reach USD 2.4 billion by 2031, growing at a CAGR of 8.1% during the forecast period from 2023 to 2031. This market growth is primarily driven by the rising prevalence of urological disorders, increasing geriatric population, and the growing adoption of minimally invasive surgical procedures. Ureteroscopes are essential diagnostic and therapeutic tools for treating kidney stones, strictures, and other upper urinary tract conditions. The transition from reusable to single-use ureteroscopes, coupled with technological innovations such as improved optics and flexible designs, continues to expand their clinical utility and market demand.

Drivers:

1. Increasing Prevalence of Urolithiasis and Urological Disorders:

The surge in lifestyle-related conditions such as obesity and dehydration has led to a growing incidence of kidney stones globally, driving demand for ureteroscopes in diagnosis and treatment.

2. Technological Advancements in Ureteroscope Design:

Miniaturization, enhanced maneuverability, digital visualization, and improved durability of ureteroscopes—particularly flexible and single-use variants—are boosting adoption rates.

3. Rise in Minimally Invasive Procedures:

As patients and clinicians increasingly prefer minimally invasive options, the role of ureteroscopes in reducing hospitalization time and surgical complications is gaining prominence.

Restraints:

1. High Cost of Advanced Ureteroscopes:

While offering superior functionality, digital and single-use ureteroscopes are often cost-prohibitive for small healthcare providers, especially in low-income regions.

2. Risk of Cross-contamination and Maintenance Issues:

Reusable ureteroscopes require meticulous sterilization, which, if not managed properly, increases infection risks and reduces product lifespan.

Opportunity:

1. Growing Adoption of Single-use Ureteroscopes:

The shift toward single-use devices offers advantages like reduced infection risk and zero reprocessing costs, making them attractive for outpatient and rural clinics.

2. Expanding Healthcare Access in Emerging Markets:

Healthcare infrastructure improvements across Asia-Pacific, Latin America, and Africa are creating new demand for urological diagnostics and treatment tools.

Market by System Type Insights:

The Flexible Ureteroscope segment held the dominant share in 2023, favored for its ease of navigation through the upper urinary tract. It enables superior visualization and treatment of renal stones, particularly in hard-to-reach areas. Single-use ureteroscopes are rapidly gaining ground due to their cost-effectiveness in high-volume settings and infection control benefits.

Market by End-use Insights:

The Hospitals segment accounted for the largest market share in 2023, owing to the availability of advanced surgical infrastructure and a high volume of endourological procedures. The Ambulatory Surgical Centers (ASCs) segment is expected to grow at the fastest pace, driven by the rising preference for same-day surgical procedures and the integration of cost-effective ureteroscopy solutions.

Market by Regional Insights:

North America led the global ureteroscope market in 2023, underpinned by a high burden of urolithiasis, favorable reimbursement policies, and widespread adoption of advanced medical technologies. Asia-Pacific is anticipated to witness the highest CAGR during the forecast period, fueled by a rising elderly population, growing medical tourism, and government initiatives to improve healthcare access.

Competitive Scenario:

Prominent companies in the ureteroscope market include Boston Scientific Corporation, Olympus Corporation, Karl Storz SE & Co. KG, Richard Wolf GmbH, Stryker Corporation, and PENTAX Medical. These firms are actively investing in product innovation, geographic expansion, and strategic partnerships.

Key Developments:

In 2023, Boston Scientific expanded its LithoVue™ portfolio with enhanced imaging capabilities.

Olympus launched a new series of high-definition flexible ureteroscopes in 2024, targeting improved surgical precision.

In 2025, Karl Storz announced a global training initiative to support endourology skill development in emerging markets.

Scope of Work – Global Ureteroscope Market

Report Metric Details